Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 32 of Pyxis Oncology, Inc.'s SEC filings and found 6 warrant series, 1 ATM program, 3 shelf registrations and 2 completed offerings on file for PYXS. The latest dilution event on file is an offering on Oct 1, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ADCTADC Therapeutics SA
RNACCartesian Therapeutics, Inc.
DTILPrecision BioSciences, Inc.
AKBAAkebia Therapeutics, Inc.
CGENCompugen Ltd
ARTVArtiva Biotherapeutics, Inc.
PRQRProQR Therapeutics N.V. Ordinary Shares
PLXProtalix BioTherapeutics, Inc.
ACIUAC Immune SA
IKTInhibikase Therapeutics, Inc.
BBOTBridgeBio Oncology Therapeutics Inc.
ELDNEledon Pharmaceuticals, Inc.
TRDAEntrada Therapeutics, Inc.
NAGENiagen Bioscience Inc
INOInovio Pharmaceuticals, Inc.